Pilgrim Partners Asia’s Transmedics TMDX Stock Holding History

Pilgrim Partners Asia’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-360	Closed	-$40.4K	–	173
2025 Q3	$40.4K	Buy	+360	New	+$42.1K	0.02%	112
2025 Q1	–	Sell	-40,000	Closed	-$2.49M	–	168
2024 Q4	$2.49M	Buy	+40,000	New	+$3.72M	2.17%	12

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Pilgrim Partners Asia's TMDX Position: Q4 2025 in Review

Pilgrim Partners Asia sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 360 shares — an estimated $40.4K sold.

Pilgrim Partners Asia first reported a position in TMDX in Q4 2024 and held it in 2 quarters. The position peaked at $2.49M in Q4 2024. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

Pilgrim Partners Asia reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
Pilgrim Partners Asia sold 360 Transmedics shares in Q4 2025, an estimated $40.4K.
Pilgrim Partners Asia first reported a position in Transmedics in Q4 2024 and held it in 2 quarters.
Pilgrim Partners Asia's Transmedics position peaked at $2.49M in Q4 2024.
428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Pilgrim Partners Asia's 13F filing for Q4 2025, filed 3 Feb 2026.